Compare Twist Bioscience Corp (TWST) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Western Digital Corp — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Western Digital Corp trades at $552.55 (market cap $168.00B). The key difference: Western Digital Corp is far larger — about 30.8× Twist Bioscience Corp's market cap, and Western Digital Corp pays a 0.12% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | WDC | |
|---|---|---|
Market Cap | $5.45B | $168.00B |
Sector | Health | Technology |
52-Week High | $102.88 | $746.23 |
52-Week Low | $24.16 | $67.06 |
Enterprise Value | $5.37B | $166.35B |
Dividend Yield | — | 0.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Western Digital (WDC) trades at $548.07, up 14.85% over 24 hours, reflecting strong momentum in memory stocks. The stock exhibits a bearish technical signal but has beaten earnings estimates for three consecutive quarters. Key financials show robust profitability with a net income margin of 55.07% and ROE of 37.73%. Recent news highlights WDC's position in the AI-driven memory and storage rebound, with institutional buying activity noted.
Outlook remains positive given analyst consensus and AI-driven demand, though valuation multiples are elevated. Risks include market volatility and competitive pressures. The consensus price target of $619.07 suggests potential upside, supported by strong institutional sentiment and fundamental improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
